Azitra, Inc.

AZTR NYSE SEC CIK 1701478
Follow Azitra Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$2.9M −6.7% vs same quarter last year
EPS, diluted −$0.29
Operating cash flow −$2.9M −18.7% vs same quarter last year
Operating income −$2.9M −4.9% vs same quarter last year
Revenue by quarter
$0
$0
$0
$0
Q4 24 Q2 25 Q3 25 Q4 25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income5 fiscal years
  • Revenue
  • Net income
−$15M−$10M−$5M$0$5MFY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$0−$11M
FY24$7.5K−$9M
FY23$686K−$11.3M
FY22$284K−$10.7M
FY21--
MarginsShare of revenue
  • Operating margin
  • Net margin
−150000%−100000%−50000%0%FY21FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY25--
FY24−146468.5%−119566.6%
FY23−1086.1%−1644.9%
FY22−3328.7%−3760.7%
FY21--
Free cash flowOperating cash flow minus capital expenditure
−$15M−$10M−$5M$0FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$11.2M
FY24−$10.2M
FY23−$7.4M
FY22−$8.4M
FY21-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Azitra
  • Healthcare median
−150000%−100000%−50000%0%FY21FY22FY23FY24FY25
Show the numbers
YearAzitraHealthcare median
FY25-−30.6%
FY24−119566.6%−47%
FY23−1644.9%−58%
FY22−3760.7%−80.4%
FY21-−71.8%